UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

The Journal of biological chemistry, 2005-01, Vol.280 (1), p.556-563

2005

Volltextzugriff (PDF)

pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation

The FASEB journal, 2007-01, Vol.21 (1), p.179-187

2007

Volltextzugriff (PDF)

Oxidative damage in Huntington's disease pathogenesis

Antioxidants & redox signaling, 2006-11, Vol.8 (11-12), p.2061-2073

2006

Volltextzugriff (PDF)

Mitochondria and Huntington's Disease Pathogenesis

Annals of the New York Academy of Sciences, 2008-12, Vol.1147 (1), p.358-382

Browne, Susan E.

2008

Volltextzugriff (PDF)

When too much ATP is a bad thing: a pivotal role for P2X7 receptors in motor neuron degeneration

Journal of neurochemistry, 2013-08, Vol.126 (3), p.301-304

Browne, Susan E.

2013

Volltextzugriff (PDF)

A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease

The Journal of pharmacology and experimental therapeutics, 2012-10, Vol.343 (1), p.167-177

2012

Volltextzugriff (PDF)

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders

The Journal of pharmacology and experimental therapeutics, 2014-09, Vol.350 (3), p.495-505

2014

Volltextzugriff (PDF)

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Human molecular genetics, 2004-04, Vol.13 (7), p.703-714

2004

Volltextzugriff (PDF)

Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis

Molecular therapy. Methods & clinical development, 2024-09, Vol.32 (3), p.101318, Article 101318

2024

Volltextzugriff (PDF)

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

European journal of pharmacology, 2014-04, Vol.728, p.31-38

2014

Volltextzugriff (PDF)

Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia–telangiectasia mice

Free radical biology & medicine, 2004-04, Vol.36 (7), p.938-942

2004

Volltextzugriff (PDF)

When too much ATP is a bad thing: a pivotal role for P2X 7 receptors in motor neuron degeneration

Journal of neurochemistry, 2013-08, Vol.126 (3), p.301-304

Browne, Susan E.

2013

Volltextzugriff (PDF)

A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone)

Journal of clinical pharmacology, 2007-12, Vol.47 (12), p.1580-1586

2007

Volltextzugriff (PDF)

A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone)

Journal of clinical pharmacology, 2007-12, Vol.47 (12), p.1580

2007

Volltextzugriff (PDF)

PISA, A novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ

Journal of pharmacological and toxicological methods, 2010-05, Vol.61 (3), p.319-328

2010

Volltextzugriff (PDF)

Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects

Movement disorders, 2010-09, Vol.25 (12), p.1924-1928

2010

Volltextzugriff (PDF)

Mitochondrial Aconitase is a Transglutaminase 2 Substrate: Transglutamination is a Probable Mechanism Contributing to High-Molecular-Weight Aggregates of Aconitase and Loss of Aconitase Activity in Huntington Disease Brain

Neurochemical research, 2005-10, Vol.30 (10), p.1245-1255

2005

Volltextzugriff (PDF)

Effects of the selective adenosine A sub(2A) receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

European journal of pharmacology, 2014-04, Vol.728, p.31-38

2014

Volltextzugriff (PDF)

N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease

Journal of neurochemistry, 2001-12, Vol.79 (5), p.1109-1112

2001

Volltextzugriff (PDF)

Brain Structures Involved in the Hypotensive Effects of Rilmenidine: Evaluation by [14C]2-Deoxyglucose Autoradiography

Journal of cardiovascular pharmacology, 1995, Vol.26 (2), p.S55-58

1995

Volltextzugriff (PDF)

Brain Structures Involved in the Hypotensive Effects of Rilmenidine: Evaluation by [14C]2-Deoxyglucose Autoradiography

Journal of cardiovascular pharmacology, 1995, Vol.26 Suppl 2, p.S55-58

1995

Volltextzugriff (PDF)

Metabolic abnormalities precede pathologic changes in the G93A SOD1 mouse model of ALS

Journal of Cerebral Blood Flow & Metabolism, 2005-08, Vol.25 (S1), p.S64-S64

2005

Volltextzugriff (PDF)

Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases

Biochemical Society transactions, 1994-11, Vol.22 (4), p.1002-1006

1994

Volltextzugriff (PDF)

Frontal Lobe Dysfunction in Progressive Supranuclear Palsy

Journal of neurochemistry, 2000-02, Vol.74 (2), p.878-881

2000

Volltextzugriff (PDF)

High risk pregnancy in the workplace. Influencing positive outcomes

AAOHN journal, 2000-09, Vol.48 (9), p.435-448

2000

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(135)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Life Sciences & Biomedicine
(79)
Humans
(66)
Male
(44)
Female
(39)
Biological And Medical Sciences
(31)
Animals
(25)
Medical Sciences
(25)
Adult
(18)
Child
(14)
Aged
(13)
Middle Aged
(13)
Adolescent
(12)
General & Internal Medicine
(11)
Mice
(10)
Public, Environmental & Occupational Health
(10)
Medicine, General & Internal
(9)
Rats
(9)
Cohort Studies
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation

Oxidative damage in Huntington's disease pathogenesis

Mitochondria and Huntington's Disease Pathogenesis

When too much ATP is a bad thing: a pivotal role for P2X7 receptors in motor neuron degeneration

A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia–telangiectasia mice

When too much ATP is a bad thing: a pivotal role for P2X 7 receptors in motor neuron degeneration

A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone)

A randomized study of the bioavailability of different formulations of coenzyme Q(10) (ubiquinone)

PISA, A novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ

Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects

Mitochondrial Aconitase is a Transglutaminase 2 Substrate: Transglutamination is a Probable Mechanism Contributing to High-Molecular-Weight Aggregates of Aconitase and Loss of Aconitase Activity in Huntington Disease Brain

Effects of the selective adenosine A sub(2A) receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease

Brain Structures Involved in the Hypotensive Effects of Rilmenidine: Evaluation by [14C]2-Deoxyglucose Autoradiography

Brain Structures Involved in the Hypotensive Effects of Rilmenidine: Evaluation by [14C]2-Deoxyglucose Autoradiography

Metabolic abnormalities precede pathologic changes in the G93A SOD1 mouse model of ALS

Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases

Frontal Lobe Dysfunction in Progressive Supranuclear Palsy

High risk pregnancy in the workplace. Influencing positive outcomes

Aktive Filter

Suchergebnisse filtern